A little pill has helped Northwestern University lead all colleges nationwide in revenue from inventions since 2008.

Lyrica, the anti-seizure drug developed by a chemistry professor, has helped the university vault to the top of a list maintained by the Association of University Technology Managers.

As reported by Crain’s Chicago Business, the $1.36 billion NU has earned, mostly from Lyrica, has left other Illinois schools in the dust, with licensing earnings of less than 10 percent of Northwestern’s.

NU now is earning more than such traditional research centers as the Massachusetts Institute of Technology and Stanford University.

Original story

Bill Smith is the editor and publisher of Evanston Now.

Leave a comment

The goal of our comment policy is to make the comments section a vibrant yet civil space. Treat each other with respect — even the people you disagree with. Whenever possible, provide links to credible documentary evidence to back up your factual claims.

Your email address will not be published. Required fields are marked *